Mr. Speaker, it may have suspended operations, but it still said it is okay to charge $2,500 for access to these clinical trials.
My supplementary is for the same minister. Three years ago, 15 year old Vanessa Young died because she was not warned about serious risks from a drug called Prepulsid. Now there is another drug being peddled in Canada by Janssen-Ortho, Eprex, which is still on the market despite grave risks with subcutaneous use by anemia patients with kidney disease. Why will the minister not join many other countries in Europe and Australia in contraindicating this dangerous use of Eprex in Canada? Will it take another death before the minister finally acts?